Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Surein Arulananda

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Internal Medicine Journal|June 21, 2018
Clinical correlates of severe thrombocytopenia from temozolomide in glioblastoma patientsSurein Arulananda, James Lynam, Mun Sem Liew, et al.
JTO Clinical and Research Reports|August 2, 2023
Real-World Analysis of Clinical Characteristics and Survival Outcomes in Patients With Extensive-Stage SCLC Treated With First-Line ChemoimmunotherapyYang Wang, Jared Mathai, Muhammad Alamgeer, et al.
Translational Lung Cancer Research|May 19, 2020
Nivolumab resulting in persistently elevated troponin levels despite clinical remission of myocarditis and myositis in a patient with malignant pleural mesothelioma: case reportGabrielle Lie, Andrew Weickhardt, Leighton Kearney, et al.
Clinical Lung Cancer|December 23, 2019
Occult Gastrointestinal Perforation in a Patient With EGFR-Mutant Non-Small-Cell Lung Cancer Receiving Combination Chemotherapy With Atezolizumab and Bevacizumab: Brief ReportAshray Gunjur, Geoff Chong, Adeline Lim, et al.
Cancers|May 13, 2023
Circulating Tumour DNA (ctDNA) as a Predictor of Clinical Outcome in Non-Small Cell Lung Cancer Undergoing Targeted Therapies: A Systematic Review and Meta-AnalysisFarzana Y Zaman, Ashwin Subramaniam, Afsana Afroz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 30, 2018
Mismatch Repair Protein Defects and Microsatellite Instability in Malignant Pleural MesotheliomaSurein Arulananda, Bibhusal Thapa, Marzena Walkiewicz, et al.
JCO Clinical Cancer Informatics|January 9, 2025
ImpACT Project: Improving Access to Clinical Trials in Victoria, an Artificial Intelligence-Based ApproachMaria L Bechelli, Kris Ivanova, Suan Siang Tan, et al.
Journal of Thoracic Disease|July 10, 2019
Standard dose osimertinib for erlotinib refractory T790M-negative <i>EGFR</i>-mutant non-small cell lung cancer with leptomeningeal diseaseSurein Arulananda, Hongdo Do, Gareth Rivalland, et al.
Annals of Translational Medicine|January 24, 2022
Lung squamous cell carcinoma with rare epidermal growth factor receptor mutation G719X: a case report and literature reviewHuanhuan Bi, Dunqiang Ren, Jieqiong Wu, et al.
BMJ Open|January 31, 2024
Implementation of a nurse-led, multidisciplinary model of care for older adults with cancer: a process evaluation protocolPolly Hypatia Dufton, Elena Tarasenko, Katrina Midgley, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Internal Medicine Journal|June 21, 2018
Clinical correlates of severe thrombocytopenia from temozolomide in glioblastoma patientsSurein Arulananda, James Lynam, Mun Sem Liew, et al.
JTO Clinical and Research Reports|August 2, 2023
Real-World Analysis of Clinical Characteristics and Survival Outcomes in Patients With Extensive-Stage SCLC Treated With First-Line ChemoimmunotherapyYang Wang, Jared Mathai, Muhammad Alamgeer, et al.
Translational Lung Cancer Research|May 19, 2020
Nivolumab resulting in persistently elevated troponin levels despite clinical remission of myocarditis and myositis in a patient with malignant pleural mesothelioma: case reportGabrielle Lie, Andrew Weickhardt, Leighton Kearney, et al.
Clinical Lung Cancer|December 23, 2019
Occult Gastrointestinal Perforation in a Patient With EGFR-Mutant Non-Small-Cell Lung Cancer Receiving Combination Chemotherapy With Atezolizumab and Bevacizumab: Brief ReportAshray Gunjur, Geoff Chong, Adeline Lim, et al.
Cancers|May 13, 2023
Circulating Tumour DNA (ctDNA) as a Predictor of Clinical Outcome in Non-Small Cell Lung Cancer Undergoing Targeted Therapies: A Systematic Review and Meta-AnalysisFarzana Y Zaman, Ashwin Subramaniam, Afsana Afroz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 30, 2018
Mismatch Repair Protein Defects and Microsatellite Instability in Malignant Pleural MesotheliomaSurein Arulananda, Bibhusal Thapa, Marzena Walkiewicz, et al.
JCO Clinical Cancer Informatics|January 9, 2025
ImpACT Project: Improving Access to Clinical Trials in Victoria, an Artificial Intelligence-Based ApproachMaria L Bechelli, Kris Ivanova, Suan Siang Tan, et al.
Journal of Thoracic Disease|July 10, 2019
Standard dose osimertinib for erlotinib refractory T790M-negative <i>EGFR</i>-mutant non-small cell lung cancer with leptomeningeal diseaseSurein Arulananda, Hongdo Do, Gareth Rivalland, et al.
Annals of Translational Medicine|January 24, 2022
Lung squamous cell carcinoma with rare epidermal growth factor receptor mutation G719X: a case report and literature reviewHuanhuan Bi, Dunqiang Ren, Jieqiong Wu, et al.
BMJ Open|January 31, 2024
Implementation of a nurse-led, multidisciplinary model of care for older adults with cancer: a process evaluation protocolPolly Hypatia Dufton, Elena Tarasenko, Katrina Midgley, et al.
Pageof 5